XANAMEM Trademark

Trademark Overview

On Tuesday, March 3, 2015, a trademark application was filed for XANAMEM with the United States Patent and Trademark Office. The USPTO has given the XANAMEM trademark a serial number of 79165819. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, August 25, 2025. This trademark is owned by ACTINOGEN LIMITED. The XANAMEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurocognitive disorders including dementia
xanamem

General Information

Serial Number79165819
Word MarkXANAMEM
Filing DateTuesday, March 3, 2015
Status706 - SECTION 71 ACCEPTED
Status DateMonday, August 25, 2025
Registration Number4824580
Registration DateTuesday, October 6, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurocognitive disorders including dementia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 2, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameACTINOGEN LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSydney NSW 2000
AU
Party NameACTINOGEN LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAU
Party NameACTINOGEN LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAU

Trademark Events

Event DateEvent Description
Saturday, May 30, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, July 1, 2015NOTICE OF PUBLICATION
Tuesday, June 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 6, 2015APPLICATION FILING RECEIPT MAILED
Monday, June 8, 2015ASSIGNED TO EXAMINER
Wednesday, June 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 30, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 22, 2016NOTIFICATION PROCESSED BY IB
Monday, November 2, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Thursday, November 5, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, December 30, 2015FINAL DISPOSITION PROCESSED
Thursday, November 10, 2016CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, November 2, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 2, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 2, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 2, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 24, 2021TEAS SECTION 71 RECEIVED
Thursday, August 11, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, August 11, 2022POST REGISTRATION ACTION MAILED - SEC.71
Friday, August 12, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 12, 2022NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Friday, April 30, 2021NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, April 27, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 12, 2022REGISTERED-SEC.71 ACCEPTED
Thursday, February 20, 2025INTERNATIONAL REGISTRATION RENEWED
Wednesday, May 28, 2025TEAS SECTION 71 RECEIVED
Thursday, February 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 15, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 15, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, October 6, 2024COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, August 25, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, August 25, 2025REGISTERED-SEC.71 ACCEPTED
Monday, August 25, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

xanamem including dementia disorders neurocognitive preparations treatment pharmaceutical